News
Cancer-fighting T-cells, the immune system's primary enforcers, are scarce in the rare kidney cancer called chromophobe renal ...
4d
TAG24 on MSNUS researchers find cancer’s secret weapon to defeat deathFat isn’t just a guilty pleasure — it’s cancer’s secret weapon. New research from UT Southwestern Medical Center is shedding light on why this is the case.In a study published this month in the ...
The proper frequency of these blood tests depends on your age and personal health status -- the most important thing is to ...
New research by Sumeda Nandadasa, Ph.D., reveals how a key protein associated with Meckel-Gruber syndrome, nephronophthisis, ...
LOS ANGELES — Living-related conjunctival limbal allograft should be first-line therapy for limbal stem cell deficiency, Edward J. Holland, MD, said during Cornea Day at the American Society of ...
Meeting Coverage > IKCS CAR T-Cell Therapy for Kidney Cancer Builds on Efficacy Record — Confirmed responses in one-fourth to one-third of patients with refractory disease by Charles Bankhead ...
NKT2152, a novel oral HIF2α inhibitor, demonstrated promising objective response rates (ORRs) for patients with previously treated advanced clear cell renal cell carcinoma (RCC), in both the all-comer ...
Collecting duct carcinoma (CDC) is an aggressive rare subtype of kidney cancer with unmet clinical needs. Little is known about its underlying molecular alterations and etiology, primarily due to its ...
There are several treatments for metastatic renal cell carcinoma (RCC), including surgery, targeted treatment, and chemotherapy. But in some cases, you might stop responding to targeted therapy ...
September 15, 2023 This study investigated the prognostic potential of baseline C-reactive protein (CRP) levels and early CRP kinetics in a real-world cohort of patients with metastatic renal cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results